[Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
Masson
C
C
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D007190:Indapamide / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D015337:Multicenter Studies as Topic; D020913:Perindopril / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012306:Risk; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004232:Diuretics; D010919:Placebos; D007190:Indapamide; D020913:Perindopril
Efficacité d'un inhibiteur de l'enzyme de conversion pour la prévention d'une récidive d'accident vasculaire cérébral.